PE20091037A1 - Nuevo uso medico de las sales de propionato de 3-(2,2,2-trimetilhidrazinio) para la profilaxis y el tratamiento de la aterosclerosis - Google Patents
Nuevo uso medico de las sales de propionato de 3-(2,2,2-trimetilhidrazinio) para la profilaxis y el tratamiento de la aterosclerosisInfo
- Publication number
- PE20091037A1 PE20091037A1 PE2008001984A PE2008001984A PE20091037A1 PE 20091037 A1 PE20091037 A1 PE 20091037A1 PE 2008001984 A PE2008001984 A PE 2008001984A PE 2008001984 A PE2008001984 A PE 2008001984A PE 20091037 A1 PE20091037 A1 PE 20091037A1
- Authority
- PE
- Peru
- Prior art keywords
- prophylaxis
- atherosclerosis
- treatment
- trimethylhydrazinium
- medical use
- Prior art date
Links
- 201000001320 Atherosclerosis Diseases 0.000 title abstract 2
- 238000011321 prophylaxis Methods 0.000 title abstract 2
- 238000011282 treatment Methods 0.000 title abstract 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 title 1
- JFWLFLLRLZSBRA-UHFFFAOYSA-N 3-[(trimethylazaniumyl)amino]propanoate;dihydrate Chemical compound O.O.C[N+](C)(C)NCCC([O-])=O JFWLFLLRLZSBRA-UHFFFAOYSA-N 0.000 abstract 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 abstract 1
- 210000000709 aorta Anatomy 0.000 abstract 1
- 230000003143 atherosclerotic effect Effects 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-M fumarate(1-) Chemical compound OC(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-M 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- PVBQYTCFVWZSJK-UHFFFAOYSA-N meldonium Chemical compound C[N+](C)(C)NCCC([O-])=O PVBQYTCFVWZSJK-UHFFFAOYSA-N 0.000 abstract 1
- 229960002937 meldonium Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
SE REFIERE AL USO DE UNA SAL DEL PROPIONATO DE 3-(2,2,2-TRIMETILHIDRAZINIO) (MELDONIO) PARA LA MANUFACTURA DE UN MEDICAMENTO PARA LA PROFILAXIS Y EL TRATAMIENTO DE ATEROSCLEROSIS. DONDE DICHAS SALES SON FOSFATO DE DIHIDROGENO Y FUMARATO DE HIDROGENO LAS CUALES SON MAS ESTABLES CON EL DIHIDRATO DE MELDONIO Y PUEDEN REDUCIR EFECTIVAMENTE LAS MANIFESTACIONES ATEROSCLEROTICAS EN LA AORTA
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07122273 | 2007-12-04 | ||
| EP07122272 | 2007-12-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20091037A1 true PE20091037A1 (es) | 2009-08-19 |
Family
ID=40481525
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2008001984A PE20091037A1 (es) | 2007-12-04 | 2008-11-27 | Nuevo uso medico de las sales de propionato de 3-(2,2,2-trimetilhidrazinio) para la profilaxis y el tratamiento de la aterosclerosis |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US20100234459A1 (es) |
| EP (1) | EP2222293B1 (es) |
| JP (1) | JP2011505408A (es) |
| KR (1) | KR20100084688A (es) |
| CN (1) | CN101951898B (es) |
| AR (1) | AR069521A1 (es) |
| AT (1) | ATE518536T1 (es) |
| AU (1) | AU2008333262A1 (es) |
| BR (1) | BRPI0819057A2 (es) |
| CA (1) | CA2706354C (es) |
| CL (1) | CL2008003551A1 (es) |
| CO (1) | CO6280477A2 (es) |
| CY (1) | CY1112336T1 (es) |
| DK (1) | DK2222293T3 (es) |
| DO (1) | DOP2010000163A (es) |
| EA (1) | EA019424B1 (es) |
| GE (1) | GEP20125673B (es) |
| HR (1) | HRP20110744T1 (es) |
| IL (1) | IL205961A0 (es) |
| MA (1) | MA31993B1 (es) |
| MX (1) | MX2010006255A (es) |
| MY (1) | MY150508A (es) |
| PA (1) | PA8805901A1 (es) |
| PE (1) | PE20091037A1 (es) |
| PL (1) | PL2222293T3 (es) |
| PT (1) | PT2222293E (es) |
| RS (1) | RS51992B (es) |
| SI (1) | SI2222293T1 (es) |
| TN (1) | TN2010000250A1 (es) |
| TW (1) | TW200930356A (es) |
| WO (1) | WO2009071585A1 (es) |
| ZA (1) | ZA201003641B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2425835A1 (en) * | 2010-08-18 | 2012-03-07 | Grindeks, a joint stock company | A new medical use of 3-(2,2,2-trimethylhydrazinium) propionate dihydrate and natural flavonoid derivatives |
| TWI487524B (zh) * | 2010-12-03 | 2015-06-11 | Tetra Sia | 菸鹼酸和米曲肼之新穎治療組合 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2535150C (en) * | 2003-08-04 | 2010-04-13 | Joint Stock Company "Grindeks" | Non-hygroscopic, stable meldonium salts, method of preparation and pharmaceutical compositions thereof |
-
2008
- 2008-11-26 TW TW097145676A patent/TW200930356A/zh unknown
- 2008-11-27 PE PE2008001984A patent/PE20091037A1/es not_active Application Discontinuation
- 2008-11-28 CL CL2008003551A patent/CL2008003551A1/es unknown
- 2008-11-28 PA PA20088805901A patent/PA8805901A1/es unknown
- 2008-12-02 AR ARP080105237A patent/AR069521A1/es unknown
- 2008-12-03 SI SI200830410T patent/SI2222293T1/sl unknown
- 2008-12-03 RS RS20110470A patent/RS51992B/sr unknown
- 2008-12-03 EP EP08857026A patent/EP2222293B1/en active Active
- 2008-12-03 HR HR20110744T patent/HRP20110744T1/hr unknown
- 2008-12-03 JP JP2010536438A patent/JP2011505408A/ja not_active Ceased
- 2008-12-03 PL PL08857026T patent/PL2222293T3/pl unknown
- 2008-12-03 MY MYPI20102603 patent/MY150508A/en unknown
- 2008-12-03 MX MX2010006255A patent/MX2010006255A/es not_active Application Discontinuation
- 2008-12-03 AU AU2008333262A patent/AU2008333262A1/en not_active Abandoned
- 2008-12-03 BR BRPI0819057 patent/BRPI0819057A2/pt not_active IP Right Cessation
- 2008-12-03 AT AT08857026T patent/ATE518536T1/de active
- 2008-12-03 DK DK08857026.2T patent/DK2222293T3/da active
- 2008-12-03 EA EA201000738A patent/EA019424B1/ru not_active IP Right Cessation
- 2008-12-03 KR KR1020107012218A patent/KR20100084688A/ko not_active Ceased
- 2008-12-03 WO PCT/EP2008/066711 patent/WO2009071585A1/en not_active Ceased
- 2008-12-03 US US12/734,779 patent/US20100234459A1/en not_active Abandoned
- 2008-12-03 PT PT08857026T patent/PT2222293E/pt unknown
- 2008-12-03 GE GEAP200811832A patent/GEP20125673B/en unknown
- 2008-12-03 CA CA2706354A patent/CA2706354C/en not_active Expired - Fee Related
- 2008-12-03 CN CN2008801194045A patent/CN101951898B/zh not_active Expired - Fee Related
-
2010
- 2010-05-21 ZA ZA2010/03641A patent/ZA201003641B/en unknown
- 2010-05-25 IL IL205961A patent/IL205961A0/en unknown
- 2010-06-01 TN TN2010000250A patent/TN2010000250A1/fr unknown
- 2010-06-02 DO DO2010000163A patent/DOP2010000163A/es unknown
- 2010-06-03 CO CO10067244A patent/CO6280477A2/es not_active Application Discontinuation
- 2010-07-01 MA MA32978A patent/MA31993B1/fr unknown
-
2011
- 2011-10-25 CY CY20111101004T patent/CY1112336T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2557303T3 (es) | Agente terapéutico para la estenosis del canal espinal | |
| SV2015005115A (es) | Derivados de la pirazolopirrolidina y su uso en el tratamiento de enfermedades | |
| UY32461A (es) | Sal de tosilato de 6-metil-5-(metil-1h-pirazol-5-il)-n-{[e-(metilsulfonil)piridin-2-il]metil -2-oxo-1-[3-(trifluorometil)fenil]-1,2-dihidropiridin-3-carboxamida | |
| SV2010003451A (es) | Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas | |
| BR112012020731A2 (pt) | pastilhas gelatinosas suaves com nicotina. | |
| MX2009013332A (es) | Inhibidores de ire-1 alfa. | |
| UY34974A (es) | Piridazina 1,4 disustituida, análogos de la misma y métodos para tratar las enfermedades relacionadas con deficiencia del smn | |
| EA201100358A1 (ru) | Дабигатран для чрескожной хирургической катетеризации сердца | |
| CO6430456A2 (es) | Derivados de aminotetralina, composiciones farmaceuticas que los contienen y sus usos en terapia | |
| MX350666B (es) | Composiciones y sus usos para tratar hiperuricemia y trastornos metabolicos asociados con hiperuricemia. | |
| CR20120316A (es) | Procesos para la fabricación de un agente farmacéuticamente activo | |
| MX346730B (es) | Composiciones y metodos para el tratamiento de la hipertension pulmonar. | |
| CL2011001829A1 (es) | 3'-n-desmetil-4''-o-(2-dietilaminoetanoil)-6-o-metil-9a-aza-9a-homoeritromicina a, sus sales y formas cristalinas 1, 2 y 3; proceso de preparacion; uso para tratar enfermedades inflamatorias; composicion farmaceutica; y composicion que ademas comprende otro compuesto activo. | |
| PA8784901A1 (es) | Utilizacion de un antagonista par1 en el tratamiento de la fibrilacion atrial | |
| CO6361995A2 (es) | Derivados de isoquinolinona como antagonistas de nk3 | |
| EA201071209A1 (ru) | Применение дронедарона или его фармацевтически приемлемой соли для получения лекарственного средства для регуляции уровня калия в крови | |
| CL2012003341A1 (es) | Composicion farmaceutica de administracion oral que compende bendamustina o un ester, una sal o un solvato de la misma, y un excipiente que es un agente tensioactivo no ionico e hidrofilico; combinacion farmaceutica; y su uso para el tratamiento de leucemia linfocitica cronica y el mieloma multiple, entre otras enfermedades. | |
| UY33453A (es) | Método para el tratamiento de la hipertensión pulmonar mediante el uso de ranozalina | |
| CO6311076A2 (es) | Una composición que comprende 2-n-butil-3-[4-(3-di-n-butilaminopropoxi)benzoil]-5-metilsulfonamido-benzofurano y sus sales aceptables farmacéuticamente | |
| DOP2010000156A (es) | Oxazolidinonas para el tratamiento y/o profilaxis de la insuficiencia cardiaca | |
| PE20091037A1 (es) | Nuevo uso medico de las sales de propionato de 3-(2,2,2-trimetilhidrazinio) para la profilaxis y el tratamiento de la aterosclerosis | |
| UY32507A (es) | Una dosis de ave5026 para el tratamiento de trombormbolismo venoso en pacientes con deterioro renal severo | |
| AR077909A1 (es) | Intervenciones de urgencia de carbon vegetal activo con sobredosificacion con etexilato de dabigatran | |
| PE20091209A1 (es) | Sales de propionato de 3-(2,2,2-trimetilhidrazinio) | |
| PE20141411A1 (es) | Nueva forma de cristal |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |